Cargando…
Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
This study investigated the changes in serum tumor marker levels in patients with breast cancer (BC) after neoadjuvant chemotherapy (NACT) and their potential as prognostic factors in NACT. A total of 134 consecutive patients with BC treated at our hospital between January 2019 and December 2021 wer...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491604/ https://www.ncbi.nlm.nih.gov/pubmed/37684327 http://dx.doi.org/10.1038/s41598-023-41836-5 |